Hyderabad-based Aurobindo Pharma has today announced that the company has received an approval from Canada for its antibiotic drug. The drug is called Cefuroxime Axetil Tablets, and is the generic version of GlaxoSmithKline's Ceftin Tablets. Aurobindo has received approval to market 250 mg and 500 mg versions of the drug. Ceftin Tablets is used to treat patients with mild to moderate infections.
This is Aurobiondo's eighth approval from Health Canada. The company has a wide-spread international presence and markets its products across 125 countries. Its manufacturing facilities are approved by various regulatory agencies from US, Canada, Brazil and South Africa.
Aurobindo manufactures both generic medicines and active pharmaceutical ingredients. Apart from antibiotics, Aurobindo has products across different areas of medicine like anti-retrovirals, anti-allergins, gastro-enterologicals, cardiovascular drugs.
